<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">After the MT-DTI prediction, the raw prediction results were screened for antiviral drugs that are FDA approved, target viral proteins, and have a 
 <italic>K
  <sub>d</sub>
 </italic> value &lt; 1000 nM. SMILES containing salt forms were excluded from the final results as the prediction is focused to pairs of a single molecule and the target protein. In addition, remdesivir was also incoprated in the analysis as its therapeutic potential to COVID-19 is recently suggested by Wang et al. 
 <xref rid="b0080" ref-type="bibr">[16]</xref> and Gliead Sciences announcements (
 <ext-link ext-link-type="uri" xlink:href="https://www.gilead.com/purpose/advancing-global-health/covid-19" id="ir010" xmlns:xlink="http://www.w3.org/1999/xlink">
  <underline>https://www.gilead.com/purpose/advancing-global-health/covid-19</underline>
 </ext-link>).
</p>
